JP2018533974A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533974A5 JP2018533974A5 JP2018536331A JP2018536331A JP2018533974A5 JP 2018533974 A5 JP2018533974 A5 JP 2018533974A5 JP 2018536331 A JP2018536331 A JP 2018536331A JP 2018536331 A JP2018536331 A JP 2018536331A JP 2018533974 A5 JP2018533974 A5 JP 2018533974A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- sequence
- protein
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201570620 | 2015-10-01 | ||
| DKPA201570620 | 2015-10-01 | ||
| DKPA201670634 | 2016-08-23 | ||
| DKPA201670634 | 2016-08-23 | ||
| PCT/DK2016/050316 WO2017054831A1 (en) | 2015-10-01 | 2016-09-30 | Use of human derived immunosuppressive proteins and peptides as medicaments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533974A JP2018533974A (ja) | 2018-11-22 |
| JP2018533974A5 true JP2018533974A5 (enExample) | 2019-10-03 |
| JP7037486B2 JP7037486B2 (ja) | 2022-03-16 |
Family
ID=57144698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018536331A Expired - Fee Related JP7037486B2 (ja) | 2015-10-01 | 2016-09-30 | 医薬としてのヒト由来免疫抑制タンパク質およびペプチドの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20190040106A1 (enExample) |
| EP (1) | EP3356389A1 (enExample) |
| JP (1) | JP7037486B2 (enExample) |
| CN (1) | CN108368155A (enExample) |
| CA (1) | CA2999792A1 (enExample) |
| WO (1) | WO2017054831A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018037042A1 (en) | 2016-08-23 | 2018-03-01 | Aimvion A/S | Novel immunostimulating peptides |
| WO2019043127A1 (en) * | 2017-09-01 | 2019-03-07 | Inprother Aps | VACCINE FOR USE IN PROPHYLAXIS AND / OR TREATMENT OF DISEASE |
| US11352421B2 (en) | 2018-12-11 | 2022-06-07 | Rush University Medical Center | Treatment for adverse immune reaction to metal implant debris |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020048763A1 (en) * | 2000-02-04 | 2002-04-25 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis |
| WO2004087748A1 (en) * | 2003-04-04 | 2004-10-14 | Centre National De La Recherche Scientifique | Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same |
| ES2347445T3 (es) * | 2004-03-30 | 2010-10-29 | Institut Gustave Roussy | Secuencia polipeptidica implicada en la modulacion del efecto inmunosupresor de las proteinas viricas. |
| EP2254592B1 (en) * | 2008-02-28 | 2019-06-05 | Dako Denmark A/S | Mhc multimers in borrelia diagnostics and disease |
| WO2011119484A1 (en) * | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
-
2016
- 2016-09-30 CN CN201680070131.4A patent/CN108368155A/zh active Pending
- 2016-09-30 CA CA2999792A patent/CA2999792A1/en not_active Abandoned
- 2016-09-30 US US15/764,714 patent/US20190040106A1/en not_active Abandoned
- 2016-09-30 EP EP16782182.6A patent/EP3356389A1/en not_active Withdrawn
- 2016-09-30 JP JP2018536331A patent/JP7037486B2/ja not_active Expired - Fee Related
- 2016-09-30 WO PCT/DK2016/050316 patent/WO2017054831A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Emili et al. | Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD | |
| JP2013513377A5 (enExample) | ||
| CN107001438A (zh) | 白细胞介素‑15组合物及其用途 | |
| MX2007002557A (es) | Uso de polipeptidos obtenidos a traves de mutaciones sistematicas de aminoacidos unicos de bloque-a humano y no humano de hmgb1 para prevenir y/o antagonizar las patologias inducidas por hmgb1. | |
| JP2012529906A5 (enExample) | ||
| JP2010501191A5 (enExample) | ||
| JP2012082206A5 (enExample) | ||
| JP2014518883A5 (enExample) | ||
| JP2019500414A5 (enExample) | ||
| RU2010122053A (ru) | Иммуносупрессорные полипептиды и нуклеиновые кислоты | |
| JP2017522325A5 (enExample) | ||
| HRP20180950T1 (hr) | Jednolančani agonistički proteini trail receptora | |
| JP2014510519A5 (enExample) | ||
| JP2021518151A5 (enExample) | ||
| JP2011144177A5 (enExample) | ||
| JP2008506357A5 (enExample) | ||
| JP2016508143A5 (enExample) | ||
| JP2024041747A5 (enExample) | ||
| FI2956471T3 (fi) | Il-1-beetan estäjän koostumus ja sen käyttö | |
| WO2018074498A8 (ja) | リムルス属由来の組換え蛋白質及びこれをコードするｄｎａ | |
| US20190077839A1 (en) | Evasins for use in therapy and diagnostics | |
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| CN111788217B (zh) | 白介素-15活性的拮抗剂肽 | |
| CN116199744B (zh) | 一种结合fgfr2受体的多肽及其用途 | |
| Dutta et al. | Optimized microwave assisted synthesis of LL37, a cathelicidin human antimicrobial peptide |